Premium Phosphosite-Specific 7TM Antibodies
Your Resource for GPCR Research
Select Your Country of Delivery below

GRK5/6 Inhibitor (Cmpd 18)

NEW
$ 150.00 *

Prices plus VAT plus shipping costs

Ready to ship today,
Delivery time appr. 5-8 days

  • 7TMGRK56-IN
  • 5 mg
Compound 18 is a potent and selective inhibitor for GRK5 and GRK6. CAS No.: 2677786-61-5... more

Compound 18 is a potent and selective inhibitor for GRK5 and GRK6.

CAS No.: 2677786-61-5

Molecular Weight: 438.91

Amount: 5 mg

Solubility: 1 mg/ml in DMSO or Methanol

Storage: - 20°C, Protected from light (in Solution: -80°C, 6 months; -20°C, 1 month; protected from light)

  IC50 (µM)   GRK2 GRK3 GRK5 GRK6 Cmpd 8h... more
  IC50 (µM)
  GRK2 GRK3 GRK5 GRK6
Cmpd 8h 2.1 3.2 >30 >30
Cmpd 18 >30 >30 11.2 8.5
Cmpd 19 >30 >30 1.5 1,1
Figure 1. Inhibition of GRK-mediated β2 adrenergic receptor (β2) phosphorylation by GRK5/6... more

Figure 1. Inhibition of GRK-mediated β2 adrenergic receptor (β2) phosphorylation by GRK5/6 Inhibitor (Cmpd 18). HEK293 ΔGRK3/5/6 (GRK2) or ΔGRK2/5/6 (GRK3) or ΔGRK2/3/6 (GRK5) or ΔGRK2/3/5 (GRK6) stably expressing the β2 were preincubated with increasing concentrations of the  GRK5/6 Inhibitor (Cmpd 18) (30 min, 37°C) prior to treatment with 10 µM isoproterenol (ISO) (30 min, 37°C). Receptor phosphorylation was assessed using the 7TM phosphorylation assay and data were normalized to 10 µM ISO without inhibitor.

Figure 2. Comparison of GRK5 inhibition of GRK-mediated β2 adrenergic receptor (β2) phosphorylation by GRK5/6 Inhibitor (Cmpd 18) or GRK5/6 Inhibitor 2 (Cmpd 19). HEK293 ΔGRK2/3/6 stably expressing the β2 were preincubated with increasing concentrations of the GRK5/6 Inhibitor (Cmpd 18) or GRK5/6 Inhibitor 2 (Cmpd 19) (30 min, 37°C) prior to treatment with 10 µM isoproterenol (ISO) (30 min, 37°C). Receptor phosphorylation was assessed using the 7TM phosphorylation assay and data were normalized to 10 µM ISO without inhibitor.

Figure 3. Comparison of GRK6 inhibition of GRK-mediated β2 adrenergic receptor (β2) phosphorylation by GRK2/3 Inhibitor (Cmpd 8h) or GRK5/6 Inhibitor 2 (Cmpd 19). HEK293 ΔGRK2/3/5 stably expressing the β2 were preincubated with increasing concentrations of the GRK5/6 Inhibitor (Cmpd 18) or GRK5/6 Inhibitor 2 (Cmpd 19) (30 min, 37°C) prior to treatment with 10 µM isoproterenol (ISO) (30 min, 37°C). Receptor phosphorylation was assessed using the 7TM phosphorylation assay and data were normalized to 10 µM ISO without inhibitor.

Figure 4. Chemical Structure of GRK5/6 Inhibitor (Cmpd 18). 

Nina K Blum, Manuela C Kiefer, Angelika Decker, Laura Klement, Edda S F Matthees, Verena... more

Nina K Blum, Manuela C Kiefer, Angelika Decker, Laura Klement, Edda S F Matthees, Verena Weitzel, Falko Nagel, Babu Joseph, Julia Drube, David Uehling, Carsten Hoffmann, Stefan Schulz. Cell-based and isoform-selective G protein-coupled receptor kinase assays for comprehensive inhibitor evaluation Commun Biol 2026 Jan 16. doi: 10.1038/s42003-026-09568-0. PMID: 41545717

Read, write and discuss reviews... more
Customer evaluation for "GRK5/6 Inhibitor (Cmpd 18)"
Write an evaluation
Evaluations will be activated after verification.

The fields marked with * are required.

Recently viewed